Skip to main content
Erschienen in: Clinical Pharmacokinetics 2/2021

14.08.2020 | Original Research Article

A Machine Learning Approach to Estimate the Glomerular Filtration Rate in Intensive Care Unit Patients Based on Plasma Iohexol Concentrations and Covariates

verfasst von: Jean-Baptiste Woillard, Charlotte Salmon Gandonnière, Alexandre Destere, Stephan Ehrmann, Hamid Merdji, Armelle Mathonnet, Pierre Marquet, Chantal Barin-Le Guellec

Erschienen in: Clinical Pharmacokinetics | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Objective

This work aims to evaluate whether a machine learning approach is appropriate to estimate the glomerular filtration rate in intensive care unit patients based on sparse iohexol pharmacokinetic data and a limited number of predictors.

Methods

Eighty-six unstable patients received 3250 mg of iohexol intravenously and had nine blood samples collected 5, 30, 60, 180, 360, 540, 720, 1080, and 1440 min thereafter. Data splitting was performed to obtain a training (75%) and a test set (25%). To estimate the glomerular filtration rate, 37 candidate potential predictors were considered and the best machine learning approach among multivariate-adaptive regression spline and extreme gradient boosting (Xgboost) was selected based on the root-mean-square error. The approach associated with the best results in a ten-fold cross-validation experiment was then used to select the best limited combination of predictors in the training set, which was finally evaluated in the test set.

Results

The Xgboost approach yielded the best performance in the training set. The best combination of covariates comprised iohexol concentrations at times 180 and 720 min; the relative deviation from these theoretical times; the difference between these two concentrations; the Simplified Acute Physiology Score II; serum creatinine; and the fluid balance. It resulted in a root-mean-square error of 6.2 mL/min and an r2 of 0.866 in the test set. Interestingly, the eight patients in the test set with a glomerular filtration rate < 30 mL/min were all predicted accordingly.

Conclusions

Xgboost provided accurate glomerular filtration rate estimation in intensive care unit patients based on two timed blood concentrations after iohexol intravenous administration and three additional predictors.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kellum JA, Lameire N, Aspelin P, Barsoum RS, Burdmann EA, Goldstein SL, et al. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1–138.CrossRef Kellum JA, Lameire N, Aspelin P, Barsoum RS, Burdmann EA, Goldstein SL, et al. Kidney disease: improving global outcomes (KDIGO) acute kidney injury work group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int Suppl. 2012;2:1–138.CrossRef
2.
Zurück zum Zitat Kirwan CJ, Philips BJ, Macphee IAM. Estimated glomerular filtration rate correlates poorly with four-hour creatinine clearance in critically ill patients with acute kidney injury. Crit Care Res Pract. 2013;2013:406075.PubMedPubMedCentral Kirwan CJ, Philips BJ, Macphee IAM. Estimated glomerular filtration rate correlates poorly with four-hour creatinine clearance in critically ill patients with acute kidney injury. Crit Care Res Pract. 2013;2013:406075.PubMedPubMedCentral
3.
Zurück zum Zitat Soveri I, Berg UB, Björk J, Elinder C-G, Grubb A, Mejare I, et al. Measuring GFR: a systematic review. Am J Kidney Dis. 2014;64:411–24.CrossRef Soveri I, Berg UB, Björk J, Elinder C-G, Grubb A, Mejare I, et al. Measuring GFR: a systematic review. Am J Kidney Dis. 2014;64:411–24.CrossRef
4.
Zurück zum Zitat Bröchner-Mortensen J. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest. 1972;30:271–4.CrossRef Bröchner-Mortensen J. A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest. 1972;30:271–4.CrossRef
5.
Zurück zum Zitat Benz-de Bretagne I, Le Guellec C, Halimi JM, Gatault P, Barbet C, Alnajjar A, et al. New sampling strategy using a Bayesian approach to assess iohexol clearance in kidney transplant recipients. Ther Drug Monit. 2012;34:289–97.CrossRef Benz-de Bretagne I, Le Guellec C, Halimi JM, Gatault P, Barbet C, Alnajjar A, et al. New sampling strategy using a Bayesian approach to assess iohexol clearance in kidney transplant recipients. Ther Drug Monit. 2012;34:289–97.CrossRef
6.
Zurück zum Zitat Taubert M, Ebert N, Martus P, van der Giet M, Fuhr U, Schaeffner E. Using a three-compartment model improves the estimation of iohexol clearance to assess glomerular filtration rate. Sci Rep. 2018;8:17723.CrossRef Taubert M, Ebert N, Martus P, van der Giet M, Fuhr U, Schaeffner E. Using a three-compartment model improves the estimation of iohexol clearance to assess glomerular filtration rate. Sci Rep. 2018;8:17723.CrossRef
7.
Zurück zum Zitat Riff C, Besombes J, Gatault P, Barbet C, Büchler M, Blasco H, et al. Assessment of the glomerular filtration rate (GFR) in kidney transplant recipients using Bayesian estimation of the iohexol clearance. Clin Chem Lab Med. 2020;58:577–87.CrossRef Riff C, Besombes J, Gatault P, Barbet C, Büchler M, Blasco H, et al. Assessment of the glomerular filtration rate (GFR) in kidney transplant recipients using Bayesian estimation of the iohexol clearance. Clin Chem Lab Med. 2020;58:577–87.CrossRef
8.
Zurück zum Zitat Åsberg A, Bjerre A, Almaas R, Luis-Lima S, Robertsen I, Salvador CL, et al. Measured GFR by utilizing population pharmacokinetic methods to determine iohexol clearance. Kidney Int Rep. 2020;5:189–98.CrossRef Åsberg A, Bjerre A, Almaas R, Luis-Lima S, Robertsen I, Salvador CL, et al. Measured GFR by utilizing population pharmacokinetic methods to determine iohexol clearance. Kidney Int Rep. 2020;5:189–98.CrossRef
9.
Zurück zum Zitat Salmon Gandonnière C, Helms J, Le Tilly O, Benz-de Bretagne I, Bretagnol A, Bodet-Contentin L, et al. Glomerular hyper- and hypofiltration during acute circulatory failure: iohexol-based gold-standard descriptive study. Crit Care Med. 2019;47:e623–e629629.CrossRef Salmon Gandonnière C, Helms J, Le Tilly O, Benz-de Bretagne I, Bretagnol A, Bodet-Contentin L, et al. Glomerular hyper- and hypofiltration during acute circulatory failure: iohexol-based gold-standard descriptive study. Crit Care Med. 2019;47:e623–e629629.CrossRef
10.
Zurück zum Zitat Badillo S, Banfai B, Birzele F, Davydov II, Hutchinson L, Kam-Thong T, et al. An introduction to machine learning. Clin Pharmacol Ther. 2020;107:871–85.CrossRef Badillo S, Banfai B, Birzele F, Davydov II, Hutchinson L, Kam-Thong T, et al. An introduction to machine learning. Clin Pharmacol Ther. 2020;107:871–85.CrossRef
12.
Zurück zum Zitat Friedman JH. Multivariate adaptive regression splines: the annals of statistics. Inst Math Stat. 1991;19:1–67. Friedman JH. Multivariate adaptive regression splines: the annals of statistics. Inst Math Stat. 1991;19:1–67.
13.
Zurück zum Zitat Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957–63.CrossRef Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993;270:2957–63.CrossRef
14.
Zurück zum Zitat Castagnet S, Blasco H, Vourc’h P, Benz-De-Bretagne I, Veyrat-Durebex C, Barbet C, et al. Routine determination of GFR in renal transplant recipients by HPLC quantification of plasma iohexol concentrations and comparison with estimated GFR. J Clin Lab Anal. 2012;26:376–83.CrossRef Castagnet S, Blasco H, Vourc’h P, Benz-De-Bretagne I, Veyrat-Durebex C, Barbet C, et al. Routine determination of GFR in renal transplant recipients by HPLC quantification of plasma iohexol concentrations and comparison with estimated GFR. J Clin Lab Anal. 2012;26:376–83.CrossRef
15.
Zurück zum Zitat Gower JC. A general coefficient of similarity and some of its properties. Biometrics. 1971;27:857–71.CrossRef Gower JC. A general coefficient of similarity and some of its properties. Biometrics. 1971;27:857–71.CrossRef
16.
Zurück zum Zitat Templ M, Kowarik A, Meindl B. Statistical disclosure control for micro-data using the R Package sdcMicro. J Stat Softw. 2015;67:1–36.CrossRef Templ M, Kowarik A, Meindl B. Statistical disclosure control for micro-data using the R Package sdcMicro. J Stat Softw. 2015;67:1–36.CrossRef
17.
Zurück zum Zitat Ryu JY, Kim HU, Lee SY. Deep learning improves prediction of drug-drug and drug-food interactions. Proc Natl Acad Sci USA. 2018;115:E4304–E43114311.CrossRef Ryu JY, Kim HU, Lee SY. Deep learning improves prediction of drug-drug and drug-food interactions. Proc Natl Acad Sci USA. 2018;115:E4304–E43114311.CrossRef
18.
Zurück zum Zitat Sheridan RP, Wang WM, Liaw A, Ma J, Gifford EM. Extreme gradient boosting as a method for quantitative structure–activity relationships. J Chem Inf Model. 2016;56:2353–60.CrossRef Sheridan RP, Wang WM, Liaw A, Ma J, Gifford EM. Extreme gradient boosting as a method for quantitative structure–activity relationships. J Chem Inf Model. 2016;56:2353–60.CrossRef
19.
Zurück zum Zitat Daunhawer I, Kasser S, Koch G, Sieber L, Cakal H, Tütsch J, et al. Enhanced early prediction of clinically relevant neonatal hyperbilirubinemia with machine learning. Pediatr Res. 2019;86:122–7.CrossRef Daunhawer I, Kasser S, Koch G, Sieber L, Cakal H, Tütsch J, et al. Enhanced early prediction of clinically relevant neonatal hyperbilirubinemia with machine learning. Pediatr Res. 2019;86:122–7.CrossRef
Metadaten
Titel
A Machine Learning Approach to Estimate the Glomerular Filtration Rate in Intensive Care Unit Patients Based on Plasma Iohexol Concentrations and Covariates
verfasst von
Jean-Baptiste Woillard
Charlotte Salmon Gandonnière
Alexandre Destere
Stephan Ehrmann
Hamid Merdji
Armelle Mathonnet
Pierre Marquet
Chantal Barin-Le Guellec
Publikationsdatum
14.08.2020
Verlag
Springer International Publishing
Erschienen in
Clinical Pharmacokinetics / Ausgabe 2/2021
Print ISSN: 0312-5963
Elektronische ISSN: 1179-1926
DOI
https://doi.org/10.1007/s40262-020-00927-6

Weitere Artikel der Ausgabe 2/2021

Clinical Pharmacokinetics 2/2021 Zur Ausgabe